VCG
SPPI

Vantage Consulting Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Vantage Consulting Group’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-29,181
Closed -$37K – 236
2021
Q4 		$37K Buy
29,181
+9,430
+48% +$16.9K 0.01% 231
2021
Q3 		$43K Buy
19,751
+9,337
+90% +$25.5K 0.01% 206
2021
Q2 		$39K Sell
10,414
-1,272
-11% -$4.42K 0.01% 211
2021
Q1 		$38K Buy
11,686
+7,020
+150% +$25.2K 0.01% 99
2020
Q4 		$16K Buy
+4,666
New +$19.2K ﹤0.01% 997

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Vantage Consulting Group's SPPI Position: Q1 2022 in Review

Vantage Consulting Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022, closing a stake of 29,181 shares — an estimated $37K sold.

Vantage Consulting Group first reported a position in SPPI in Q4 2020 and held it in 5 quarters. The position peaked at $43K in Q3 2021. 101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.

  • Vantage Consulting Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Vantage Consulting Group sold 29,181 Spectrum Pharmaceuticals Inc shares in Q1 2022, an estimated $37K.
  • Vantage Consulting Group first reported a position in Spectrum Pharmaceuticals Inc in Q4 2020 and held it in 5 quarters.
  • Vantage Consulting Group's Spectrum Pharmaceuticals Inc position peaked at $43K in Q3 2021.
  • 101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.

Based on Vantage Consulting Group's 13F filing for Q1 2022, filed 16 May 2022.